ISCO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ISCO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
International Stem Cell's yield on cost for the quarter that ended in Dec. 2024 was 0.00.
The historical rank and industry rank for International Stem Cell's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Biotechnology subindustry, International Stem Cell's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, International Stem Cell's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where International Stem Cell's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of International Stem Cell is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
International Stem Cell (OTCPK:ISCO) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of International Stem Cell's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul V Maier | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
Andrei Semechkin | 10 percent owner | 1 OVERLOOK DR. UNIT 11, AMHERST NH 03031 |
Sofya Bakalova | officer: Dir. of Legal Affairs & Oper. | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
Wright Don | director | 2829 RUCKER AVE, 3RD FLOOR, EVERETT WA 98201 |
Jennifer Stephens | officer: Acting Chief Financial Officer | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
Mahnaz Ebrahimi | officer: Chief Financial Officer | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
Rouslan Semechkin | director, 10 percent owner | 2595 JASON CT, OCEANSIDE CA 92056 |
Tibor Jay Novak | officer: Interim CFO | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
John Simon Craw | officer: Executive Vice President | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
James H Berglund | director | C/O INTERNATIONAL STEM CELL CORPORATION, 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
Ar Partners Llc | 10 percent owner | 5950 PRIESTLY DR., CARLSBAD CA 92008 |
Kurt Andrew May | officer: President and COO | 5950 PRIESTLY DRIVE, CARLSBAD CA 92008 |
Linh T Nguyen | officer: Chief Financial Officer | 5950 PRIESTLY DR., CARLSBAD CA 92008 |
Jeffrey Janus | director, officer: President | 2595 JASON COURT, OCEANSIDE CA 92056 |
Charles J Casamento | director | 99 BELBROOK WAY, ATHERTON CA 94027 |
From GuruFocus
By Marketwired Marketwired • 02-13-2019
By Marketwired Marketwired • 08-21-2018
By Marketwired Marketwired • 05-14-2018
By ACCESSWIRE ACCESSWIRE • 03-30-2022
By Marketwired Marketwired • 01-15-2019
By Marketwired Marketwired • 03-04-2019
By pjbosc • 05-25-2011
By ACCESSWIRE ACCESSWIRE • 05-17-2022
By Marketwired Marketwired • 04-18-2018
By Marketwired Marketwired • 04-29-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.